Quantoom Biosciences

End of february, CAPTIVATE-EU wrapped its annual Meeting in Barcelona!   🎥 Meet Erica Pasini from BPRC and our scientist Youlia Serikova from Quantoom Biosciences, who took a moment after the session to share their key takeaways and ambitions for the project moving forward. Watch the video to learn more about their work! https://lnkd.in/eNXG8dmi 🔬 Together, we are making great strides: ✅ BPRC is optimizing the efficacy of current pre-erythrocytic vaccines. ✅ Quantoom Biosciences is evaluating the safety and immunogenicity of new blood-stage mRNA vaccine candidates.   Through collaboration and innovation, Quantoom Biosciences is contributing to CAPTIVATE real impact in the fight against malaria. Stay tuned for more updates as we work toward our shared goal of developing a multistage malaria vaccine! 💡🌍   📢 Learn more on our website: https://lnkd.in/e_w9iXiq 📢 Learn more on captivate’s website: https://lnkd.in/ecP_NQA6   🔗 PROJECT PARTNERS Leiden University Medical Center European Vaccine Initiative (EVI) DKFZ German Cancer Research Center ImmuneWatch NEC OncoImmunity AS Quantoom Biosciences BPRC UNSW   #CaptivateEu #CaptivateMalariaVaccine #EUFunded   This project has received funding from the European Union’s Horizon Europe research and innovation programme under grant agreement No 101081028.

[ON-DEMAND WEBINAR] mRNA vaccines are transforming healthcare with rapid development and unmatched adaptability—crucial for fighting infectious diseases. 💉🔬 Join our on-demand webinar to discover how Ntensify® mano streamlines RNA production and purification, accelerating the path from preclinical research to first-in-human trials. 🚀 📢 Don’t miss out! Access the webinar now: https://shorturl.at/49jMI  #mRNA #Vaccines #Biotech #InfectiousDiseases

🆕 The Centre for Veterinary Vaccine Innovation and Manufacturing (CVIM), based at Pirbright, has partnered with Quantoom Biosciences to accelerate mRNA and saRNA vaccine development for livestock. Using Quantoom’s Ntensify® mini platform, the collaboration has already delivered outstanding results for peste des petits ruminants virus (PPRV) in sheep and now it's expanding to tackle other livestock diseases, such as bluetongue virus. Full story ➡️ https://ow.ly/7f8q50VhfUS 📸: Quantoom Biosciences #AnimalHealth #OneHealth

🚀 PRESS RELEASE: The Pirbright Institute Adopts Quantoom’s Ntensify® mini for mRNA Vaccine Research! We’re thrilled to announce that The Centre for Veterinary Vaccine Innovation and Manufacturing (CVIM), part of The Pirbright Institute, has adopted Quantoom Biosciences’ Ntensify® mini to advance its mRNA and saRNA vaccine development at its UK site! With Ntensify® mini, The Pirbright Institute will have a research-grade mRNA and saRNA production platform that will enable cost-effective, high-quality RNA synthesis and purification, significantly accelerating the institute’s ability to develop next-generation vaccines. 💡 Want to learn more? Read the full press release here: https://shorturl.at/aHu9c #RNARevolution #VaccineInnovation #mRNA #saRNA #AnimalHealth #OneHealth #Biotech #PirbrightInstitute #Quantoom #Ntensify

🚀 Quantoom Biosciences Expands India’s GMP RNA Manufacturing Capabilities through a Partnership with Techinvention Lifecare Pvt. Ltd. ! Last week, during the Belgian Economic Mission, representatives from TechInvention and Quantoom Biosciences gathered at TechInvention’s Mumbai site, joined by Dominique Delattre, Deputy General Manager at Wallonia Export & Investment Agency (AWEX), to strengthen their commitment to advancing RNA manufacturing in India. 🇮🇳🇧🇪 This partnership will bring Quantoom’s RNA N-Force toolbox to India, enabling TechInvention to develop, manufacture, and commercialize next-generation RNA-based medicines, making them more accessible, scalable, and affordable. 📢 Read the full press release published last week here: https://shorturl.at/eJ1s8 🔗 Learn more about this collaboration in: ➡ Manufacturing Chemist: https://shorturl.at/hJ49F ➡ BioSpectrum India: https://shorturl.at/eGbgP #BiotechInnovation #RNARevolution #PartneringForGlobalHealth #BEmissionIND #GMP #TechInvention #Quantoom With Sudhir Kumar Sharma and Uday Ulhe

🔔 The training is coming up soon – and there are still a few spots available! If you’re looking to gain exclusive insights into the future of mRNA production and biopharma automation, this is your chance! 🚀 📅 Don’t miss out – secure your spot now! 😊 📍 Info & Registration: https://lnkd.in/eex5Ys2Y #Biopharma #Innovation #Automation #mRNA #Training #Robotics

🇧🇪🇮🇳 Belgian Economic Mission to India! (March 1-8) Yesterday in New Delhi, our team participated in an insightful seminar, “Innovation for a Healthier World: Uniting Strengths from India and Belgium.” Our CEO, Jose Castillo, was honored to speak on the panel “Collaborative Innovation in Vaccine Development,” led by the Gates Foundation. The discussion focused on the challenges and opportunities of advancing vaccine development through collaboration, highlighting the powerful Indian-Belgian partnerships driving innovation in global health. An inspiring exchange of ideas! 🚀 #BEmissionIND #Innovation #VaccineDevelopment #GlobalHealth #Collaboration

🚀 Join our exclusive webinar on accelerating mRNA vaccine development! mRNA technology is revolutionizing vaccine development, offering unmatched speed, adaptability, and scalability—critical for addressing emerging infectious diseases. But how can we further streamline the process? 🔬 In this 30-minute session, our experts will discuss how Ntensify® mano enables faster, scalable, and risk-minimized vaccine development. 📅 Thursday, March 13 ⏰ 9:00 AM CET | 10:00 AM Cairo | 4:00 PM SG | 7:00 PM AUS | 9:00 PM NZ 📍 Duration: 30 minutes 🔗 Register now: https://lnkd.in/exYj-NaN Join us to gain valuable insights from industry experts and discover how to optimize mRNA vaccine development for infectious diseases! #Webinar #mRNA #mRNAVaccine #VaccineDevelopment #BiotechInnovation #InfectiousDiseases

🔬 Quantoom Biosciences is at RNA Leaders Europe 2024 in Basel, Switzerland! (March 4-6) 📍 Visit us at Booth #17 to discover how we’re reinventing mRNA production with our cutting-edge technologies. 🚀 We’re excited to connect, exchange insights, and discuss the future of RNA therapeutics—let’s shape the next wave of innovation together! #RNA #mRNA #Innovation #Biotech #RNAtherapeutics #Conference

🌍 PRESS RELEASE: India and Belgium Join Forces to Advance RNA-Based Vaccines! We are thrilled to announce the signing of a Memorandum of Understanding (MoU) between Techinvention Lifecare Pvt. Ltd. and Quantoom Biosciences, marking a major step forward in RNA-based vaccine development. The agreement was formalized yesterday in New Delhi during an official signing ceremony attended by HRH Princess Astrid of Belgium, as part of the Belgian Economic Mission to India 🇧🇪🇮🇳. This landmark collaboration was signed by Syed Ahmed, Director & CEO of TechInvention, and Jose Castillo, CEO of Quantoom Biosciences. By bringing Quantoom’s cutting-edge RNA N-Force toolbox to India, TechInvention aims to accelerate the development of accessible, scalable, and affordable RNA-based solutions. With the RNA N-Force Toolbox as a foundation, TechInvention will leverage its expertise in translational research, regulatory pathways, and GMP manufacturing to streamline the development, scale-up, and commercialization of next-generation RNA-based products. 📢 Learn more about this collaboration: https://shorturl.at/eJ1s8 #BiotechInnovation #PartneringForGlobalHealth #BEmissionIND